MBAI

+ Watchlist + Portfolio

Check-Cap Ltd.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.16
52-Week Range: $3.03 – $27.44
Market Cap: $50.32M
P/E (TTM): 0.71
EPS (TTM): 4.65
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 27.88
PEG Ratio: —
Return on Equity: 39.22%
Return on Assets: 17.15%
Gross Margin: 55.20%
Operating Margin: 21.34%
Profit Margin: 21.75%
Current Ratio: 2.01
Debt/Equity: —
Total Debt: —
Free Cash Flow: $-594.19K
Revenue Growth: —
Earnings Growth: —
Enterprise Value: —

MBAI Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Diluted EPS	-3.37	-3.00	-4.30	0.66
Diluted Shares	5.67M	5.85M	5.85M	6.23M

MBAI Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$4.09M	$8.84M	$0.00	$2.00K
Current Assets	$42.63M	$24.86M	$265.00K	$219.00K
Total Assets	$45.44M	$25.02M	$377.00K	$7.49M
Current Liabilities	$3.41M	$1.33M	$1.81M	$4.05M
Total Debt	$964.00K	$0.00	$136.00K	$16.00K
Total Liabilities	$4.13M	$1.33M	$1.83M	$4.05M
Retained Earnings	-$127.29M	-$144.86M	-$170.01M	-$165.87M
Shareholders' Equity	$41.31M	$23.69M	-$1.45M	$3.44M
Working Capital	$39.22M	$23.53M	-$1.55M	-$3.83M

MBAI Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$18.71M	-$16.95M	-$8.00M	-$46.00K
Capital Expenditure	-$486.00K	-$83.00K	—	—
Free Cash Flow	-$19.19M	-$17.04M	-$8.00M	-$46.00K
Depreciation & Amortisation	$404.00K	$212.00K	$161.00K	$0.00
Stock-Based Compensation	$879.00K	-$57.00K	$12.00K	-$12.00K
Investing Cash Flow	-$12.51M	$21.36M	-$840.00K	$48.00K
Financing Cash Flow	$8.85M	$0.00	$0.00	$0.00
Net Change in Cash	-$22.36M	$4.40M	-$8.84M	$2.00K

MBAI Balance Sheet statement, quarterly periods, in USD
USD	Q4 2024	Q2 2025	Q4 2025
Cash & Equivalents	$0.00	$1.16M	$2.00K
Current Assets	$265.00K	$1.42M	$219.00K
Total Assets	$377.00K	$5.76M	$7.49M
Current Liabilities	$1.81M	$1.99M	$4.05M
Total Debt	$136.00K	$139.00K	$16.00K
Total Liabilities	$1.83M	$2.00M	$4.05M
Retained Earnings	-$170.01M	-$164.80M	-$165.87M
Shareholders' Equity	-$1.45M	$3.76M	$3.44M
Working Capital	-$1.55M	-$569.00K	-$3.83M

Market Snapshot

About

Check-Cap develops medical devices for colorectal cancer screening. The company is focused on innovative imaging capsule technology for non-invasive colon examination.